Q32 Bio: "Buy" On Bempikibart Advancement And Mid-2026 Data Catalysts
Akebia Therapeutics Inc AKBA
$1.05
▲ +1.94%
(+$0.02)
Open
$1.04
Prev Close
$1.03
Day Range
$1.01 – $1.07
52W Range
$0.88 – $4.08
Market Cap
$278.99M
Beta
0.28
EPS (TTM)
$-0.08
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-03-20 |
| Shares Out. | 268,260,000 |
| Website | akebia.com/ ↗ |
| Phone | 13026587581 |
Akebia Therapeutics Inc is a publicly traded company under the ticker symbol AKBA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)